: The way Medicare will negotiate down prescription drug prices takes shape

January 11, 2023

Read Time:4 Second

Biden administration releases timeline for negotiations as policy experts debate pharmaceutical industry impact

About Post Author

Happy

0 %

Sad

0 %

Excited

0 %

Sleepy

0 %

Angry

0 %

Surprise

0 %

Regeneron’s stock dips after earnings fall short of estimates

Regeneron Pharmaceuticals’ stock fell 2.6% premarket Thursday, after the drug company’s first-quarter profit and revenue fell short of analyst estimates.

May 2, 2024

We’re all paying a high price for letting corporations have free rein over us

Deliberately weakening social protections has created greater financial and economic insecurity.

May 2, 2024

Intel and Microsoft are on different paths to profit from AI. One will be right.

Tech giants’ recent earnings reveal a clear winner in market leadership and momentum.

May 2, 2024

Novartis to pay up to $1.75 billion for U.S. cancer-focused biotech

Novartis on Thursday said it will pay up to $1.75 billion for a U.S. biotech focused on cancer.

May 2, 2024

What if you could take your existing mortgage with you to a new house?

Here’s the key that could unlock the U.S. housing market for buyers and sellers.

May 2, 2024

My grandmother’s house was split between her 10 kids almost 50 years ago. How do we figure out the cost basis?

If the property has been held for a long time things can become complicated.

May 2, 2024

: The way Medicare will negotiate down prescription drug prices takes shape

About Post Author

Wall Street Today

Other

Business